Chewy Stock Shows Potential for Value Recovery
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy CHWY?
Source: Fool
- Consistent Sales Growth: Chewy achieved $12.6 billion in net sales for fiscal 2025, reflecting a 6% year-over-year increase that led to a 125% surge in operating income, demonstrating resilience and boosting investor confidence amid market challenges.
- Net Income Fluctuations: The net income of $223 million in fiscal 2025, down from $393 million the previous year, was influenced by a $241 million income tax benefit, highlighting the complexities in financial management and the need for careful analysis of earnings reports.
- Strengthened Competitive Advantage: Chewy has solidified its market position by offering low prices alongside superior customer service, and during the pandemic, it expanded into pharmaceuticals and telehealth services for pets, which could significantly enhance future sales.
- Attractive Valuation: Although Chewy's trailing P/E ratio stands at 50, above the S&P 500 average of 31, analysts project a 9% increase in net sales and a 28% rise in net income for the upcoming fiscal year, resulting in a forward P/E ratio of just 16, indicating strong investment potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CHWY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CHWY
Wall Street analysts forecast CHWY stock price to rise
20 Analyst Rating
17 Buy
3 Hold
0 Sell
Strong Buy
Current: 25.420
Low
42.00
Averages
47.06
High
52.00
Current: 25.420
Low
42.00
Averages
47.06
High
52.00
About CHWY
Chewy, Inc. is an e-commerce business geared toward pet products and services. The Company’s products consist of pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. It serves its customers through its retail websites, and its mobile applications and focuses on delivering customer service, competitive prices, convenience, including Chewy’s Autoship subscription program, and a range of pet food, treats and supplies, and pet healthcare products and services. It partners with approximately 3,200 of the brands in the pet industry, and it creates and offers its own private brands. It owns a number of trademark registrations and applications in the United States and in foreign jurisdictions. These trademarks include American Journey, Blue Box Event, Careplus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Consistent Sales Growth: Chewy achieved $12.6 billion in net sales for fiscal 2025, reflecting a 6% year-over-year increase that led to a 125% surge in operating income, demonstrating resilience and boosting investor confidence amid market challenges.
- Net Income Fluctuations: The net income of $223 million in fiscal 2025, down from $393 million the previous year, was influenced by a $241 million income tax benefit, highlighting the complexities in financial management and the need for careful analysis of earnings reports.
- Strengthened Competitive Advantage: Chewy has solidified its market position by offering low prices alongside superior customer service, and during the pandemic, it expanded into pharmaceuticals and telehealth services for pets, which could significantly enhance future sales.
- Attractive Valuation: Although Chewy's trailing P/E ratio stands at 50, above the S&P 500 average of 31, analysts project a 9% increase in net sales and a 28% rise in net income for the upcoming fiscal year, resulting in a forward P/E ratio of just 16, indicating strong investment potential.
See More
- Revenue Growth: Chewy reported $12.6 billion in net sales for fiscal 2025, reflecting a 6% year-over-year increase, indicating that the company continues to grow despite market pressures, thereby enhancing its competitive position in the pet supply market.
- Profitability Improvement: Although net income for fiscal 2025 was $223 million, down from $393 million the previous year, a $241 million income tax benefit contributed to a 125% spike in operating income, showcasing the company's potential for profitability.
- Cash Flow Enhancement: Chewy's free cash flow increased by 24% year-over-year to $562 million, indicating improved financial management and the ability to control its destiny, which supports future expansion plans.
- Competitive Advantage: By offering low prices and superior customer service, along with the introduction of pet pharmaceuticals and telehealth services during the pandemic, Chewy has solidified its market position, which is expected to drive sales growth in the future.
See More
- Stock Performance: Chewy (CHWY) fell 5.14% to $25.65 in the latest trading session, underperforming the S&P 500's 0.41% decline, indicating market concerns about its future performance.
- Earnings Expectations: The upcoming earnings report is expected to show an EPS of $0.43, a 22.86% increase year-over-year, with revenue projected at $3.36 billion, reflecting a 7.87% growth, suggesting the company still has growth potential in a competitive market.
- Analyst Ratings: Chewy currently holds a Zacks Rank of #2 (Buy), with a 10.64% upward revision in EPS projections over the past 30 days, indicating analysts' confidence in the company's future performance, which may influence short-term stock movements.
- Valuation Analysis: Chewy's forward P/E ratio stands at 16.64, below the industry average of 17.61, and its PEG ratio is 0.64, suggesting a lower valuation compared to the industry, which may attract value investors' interest.
See More
- Stock Rebound: Chewy's stock has risen nearly 14% and 19% in the week and month ending April 20, respectively, indicating a renewed market confidence despite still being 40.64% below its 52-week high.
- Growth Potential: Chewy's revenue is steadily increasing at around 8% annually, with operating margins expected to grow by over 100 basis points this year and nearly double by 2030, highlighting its potential for improved profitability.
- Subscription Business Advantage: Chewy's autoship subscription service not only enhances customer loyalty but also provides a margin-expanding platform, as much of the advertising-driven purchases come from these orders, strengthening the company's competitive position.
- Acquisition Strategy: Chewy's acquisition of Modern Animal is projected to add over $125 million in annualized revenue and increase its physical locations from 18 to 47, showcasing its expansion potential in the pet healthcare market, which could enhance overall profitability.
See More
- Stock Rebound Signs: Chewy's stock has risen nearly 14% and 19% in the week and month ending April 20, respectively, indicating market optimism about its future, despite still being 40.64% below its 52-week high.
- Stable Revenue Growth: Chewy's revenue is steadily rising at an 8% rate, with significant earnings growth expected to lead to over 100 basis points increase in operating margins this year, potentially nearly doubling by 2030, indicating enhanced competitiveness in the market.
- Subscription Business Advantage: Chewy's autoship subscription service not only boosts customer loyalty but also serves as a margin-expanding platform, as a significant portion of advertising-driven purchases comes from autoship orders, further solidifying its market position.
- Acquisition Strategy: Chewy's acquisition of Modern Animal is expected to add over $125 million in annualized revenue and increase its physical store count from 18 to 47, demonstrating its ambition in expanding offline operations, which could enhance overall profitability.
See More
- New Evidence in Antitrust Case: California's Attorney General released documents revealing internal communications between Amazon and major vendors, indicating alleged coercion to raise prices at rival retailers like Walmart and Target, thereby stifling competition and impacting consumer pricing.
- Price Manipulation Allegations: Amazon is accused of pressuring brands such as Levi Strauss and Hanes to inflate prices on competing platforms, resulting in higher costs for consumers across multiple sites and further entrenching its dominant market position.
- Legal Action Request: The Attorney General's office has requested the court to prohibit Amazon from continuing these alleged price-fixing practices and to appoint an independent monitor to ensure compliance, reflecting serious concerns over Amazon's market behavior.
- Market Share Impact: With Amazon controlling up to 50% of the U.S. e-commerce market, its pricing strategies are seen as a primary factor driving up prices for competitors, potentially leading to significant implications for future market dynamics and consumer choices.
See More











